BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2298126)

  • 1. [Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy].
    Hilz MJ; Druschky KF; Bauer J; Neundörfer B; Schuierer G
    Dtsch Med Wochenschr; 1990 Jan; 115(3):93-7. PubMed ID: 2298126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine.
    Lowette KF; Desmet K; Witters P; Laleman W; Verslype C; Nevens F; Fevery J; Cassiman DM
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):564-71. PubMed ID: 20042865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelation treatment of neurological Wilson's disease.
    Walshe JM; Yealland M
    Q J Med; 1993 Mar; 86(3):197-204. PubMed ID: 8369040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy.
    Dingle J; Havener WH
    Ann Ophthalmol; 1978 Sep; 10(9):1227-30. PubMed ID: 736410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
    Hampel R; Meng W; Kallwellis G
    Z Gesamte Inn Med; 1976 Jul; 31(13):507-11. PubMed ID: 960872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilson's disease presenting as haemolytic anaemia and its successful treatment with penicillamine and zinc.
    Kong HL; Yap IL; Kueh YK
    Singapore Med J; 1996 Dec; 37(6):670-2. PubMed ID: 9104075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.
    Scheinberg IH; Jaffe ME; Sternlieb I
    N Engl J Med; 1987 Jul; 317(4):209-13. PubMed ID: 3600712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [True hepatic Wilson's disease].
    Ciravegna B; Giacchino R; Marazzi MG
    Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the treatment of Wilson's disease with zinc sulfate and d-penicillamine].
    Szleper M; Rodo M; Piłkowska E; Członkowska A
    Pol Tyg Lek; 1992 May 18-25; 47(20-21):456-8. PubMed ID: 1437767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy in Wilson's disease.
    Walshe JM
    Q J Med; 1977 Jan; 46(181):73-83. PubMed ID: 866569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathological findings in penicillamine-treated patients with Wilson's disease.
    Horoupian DS; Sternlieb I; Scheinberg IH
    Clin Neuropathol; 1988; 7(2):62-7. PubMed ID: 3390974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.